Overall, our study indicates that DLX6-AS1 plays a regulatory role in development and metastasis of BC through miR-195-5p-mediated VEGFA/Ras/Raf/MEK/ERK signaling pathway, and the DLX6-AS1 may be a potential biomarker and target for BC. Here, DLX6 is linked to breast cancer.